Managing logistics for CAR T-cell therapy in children with neuroblastoma and osteosarcoma
GD2 CAR-T CELL THERAPY CLINICAL TRIAL SITE ADMINISTRATION AND CELL DISTRIBUTION LOGISTICS
This study is working to make sure that children with neuroblastoma and osteosarcoma can get their CAR T-cell therapy more quickly and easily, so they can have better access to this important treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-10281330 on NIH RePORTER |
What this research studies
This research focuses on the logistics involved in distributing CAR T-cell therapy products for children diagnosed with neuroblastoma and osteosarcoma. It aims to streamline the processes of collecting, manufacturing, and delivering these personalized cell therapies to ensure they reach patients efficiently. By standardizing procedures and enhancing coordination among clinical trial sites, the research seeks to improve the overall effectiveness of this innovative treatment. Patients will benefit from a more reliable and timely access to potentially life-saving therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with neuroblastoma or osteosarcoma who are eligible for CAR T-cell therapy.
Not a fit: Patients with cancers other than neuroblastoma or osteosarcoma may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the delivery and accessibility of CAR T-cell therapies for pediatric patients with specific cancers.
How similar studies have performed: Other research has shown success in CAR T-cell therapies for various cancers, indicating a promising potential for this approach in pediatric populations.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Dmitrovsky, Ethan — Leidos Biomedical Research, INC.
- Study coordinator: Dmitrovsky, Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.